Literature DB >> 6975607

Manual coronary endarterectomy with saphenous bypass: experience with 263 patients.

E Wallsh, A J Franzone, R H Clauss, C Armellini, F Steichen, S H Stertzer.   

Abstract

From January, 1972, until August, 1980, 271 manual coronary endarterectomies with bypass were performed in 263 patients. All patients underwent additional cardiac procedures simultaneously. The group contained 254 distal right and 17 left endarterectomies (including 8 double endarterectomies). Clinical follow-up was 100%, operative mortality was 2.3% (6 out of 263), and the rate of perioperative infarction was 4.9% (13 out of 263). Cineangiography was performed on 72 patients between 1 and 60 months after operation (mean, 15.4 months). Patency was 85% (61 out of 72). Endarterectomy in a dominant right coronary artery could be planned electively. Left coronary endarterectomy was performed only when diffuse disease prevented standard bypass. Coronary endarterectomy may be used to extend operability with excellent clinical results, low perioperative mortality, and high late patency. Careful attention to technical aspects of core removal and myocardial protection are necessary for consistent results.

Entities:  

Mesh:

Year:  1981        PMID: 6975607     DOI: 10.1016/s0003-4975(10)61776-6

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  3 in total

Review 1.  Coronary endarterectomy for the diffusely diseased coronary artery.

Authors:  Kosaku Nishigawa; Toshihiro Fukui; Shuichiro Takanashi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-05-10

2.  Bypass grafting to the right coronary artery with and without endarterectomy: patency at one year.

Authors:  P H Kay; N Brooks; P Magee; M F Sturridge; R K Walesby; J E Wright
Journal:  Br Heart J       Date:  1985-11

3.  Long term survival after coronary endarterectomy in patients undergoing combined coronary and valvular surgery--a fifteen year experience.

Authors:  Sanjay Kumar; Sandeep Agarwala; Charlie Talbot; R Unnikrishnan Nair
Journal:  J Cardiothorac Surg       Date:  2008-03-26       Impact factor: 1.637

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.